Oncology Nursing News®

Web Exclusives

FDA Grants Priority Review to Atezolizumab for Frontline NSCLC Treatment

FDA Grants Priority Review to Atezolizumab for Frontline NSCLC Treatment

BY BRIELLE BENYON

Drug Combination Is Promising in Bladder Cancer Subset

Drug Combination Is Promising in Bladder Cancer Subset

BY BRIELLE BENYON

FDA Grants Priority Review to Lurbinectedin to Treat SCLC

FDA Grants Priority Review to Lurbinectedin to Treat SCLC

BY GINA COLUMBUS

Consider These 3 Things Before Determining Myeloma Treatment

Consider These 3 Things Before Determining Myeloma Treatment

BY BRIELLE BENYON

Ilixadencel Added to Sunitinib May Improve RCC Outcomes

Ilixadencel Added to Sunitinib May Improve RCC Outcomes

BY GINA COLUMBUS

Immunotherapy Plus Chemo Improves Metastatic TNBC Outcomes

Immunotherapy Plus Chemo Improves Metastatic TNBC Outcomes

BY GINA COLUMBUS

FDA Grants CAR T-Cell Therapy a Priority Review for Large B-Cell Lymphoma

FDA Grants CAR T-Cell Therapy a Priority Review for Large B-Cell Lymphoma

BY BRIELLE BENYON

Nutritional Status Misjudged by Pediatric Oncology Nurses

Nutritional Status Misjudged by Pediatric Oncology Nurses

BY BRIELLE BENYON

FDA Grants Priority Review to KTE-X19 for Treatment of Mantle Cell Lymphoma

FDA Grants Priority Review to KTE-X19 for Treatment of Mantle Cell Lymphoma

BY HANNAH SLATER

Advanced NSCLC: Expert Talks Recent Advancements, Shortcomings

Advanced NSCLC: Expert Talks Recent Advancements, Shortcomings

BY BRIELLE BENYON

External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc

OncNurse Resources

Newsroom
Continuing Education
Discussions
Web Exclusives

About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions

Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.